Teleconcussion Assessments Are Feasible for Football Players

This article originally appeared here.
Share this content:
Teleconcussion Assessments Are Feasible for Football Players
Teleconcussion Assessments Are Feasible for Football Players

MONDAY, May 1, 2017 (HealthDay News) -- Teleconcussion assessment with a remote neurologist assessing football players using a telemedicine robot is feasible for sideline concussion assessments, with high levels of agreement with face-to-face providers, according to a study published online March 24 in Neurology.

Bert B. Vargas, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues assessed a cohort of 11 consecutive male collegiate football players with suspected concussion using Standardized Assessment of Concussion (SAC), King-Devick test (K-D), and modified Balance Error Scoring System (mBESS). Each athlete was assessed by a remote neurologist using a telemedicine robot with real-time two-way audiovisual capabilities and by a sideline provider who performed a simultaneous face-to-face assessment. A remove-from-play (RFP) determination was made after the assessment. SAC and mBESS scores were obtained for six of the 11 athletes.

The researchers found that in all six cases assessed, the teleconcussion and face-to-face SAC were in agreement. There was a mean difference of 0.7 seconds between remote and sideline K-D times. In all 11 cases, remote and sideline K-D were within a 3-second difference. In all six cases assessed, remote and sideline mBESS scores were within 3 points. In all 11 cases, RFP decisions were in agreement.

"These data suggest a high level of agreement between remote and face-to-face providers with regard to examination findings and RFP determinations," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »